Grow your business safely with ALMA BIO THERAPEUTICS

All the information you need about ALMA BIO THERAPEUTICS to develop and secure your business in France

A HOME > CORPORATES > ALMA BIO THERAPEUTICS > BALANCE SHEET ( 2018-12-11)

THE LIST OF BALANCE SHEET : ALMA BIO THERAPEUTICS

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2021-11-04 Public 2020-12-31 Complete
2021-01-05 Public 2019-12-31 Complete
2019-12-16 Public 2018-12-31 Complete
2018-12-11 Public 2017-12-31 Complete
2018-01-17 Public 2016-12-31 Complete
NameALMA BIO THERAPEUTICS
Siren798709309
Closing2017-12-31
Registry code 6901
Registration number B2018/050125
Management number2013B06068
Activity code 7490B
Closing date n-12016-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2018-12-11
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address69007 LYON
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 201 313.00 72 496.00 128 817.00 201 313.00
AT Other tangible assets 2 629.00 2 329.00 300.00 2 629.00
BH Other financial assets 8 025.00 8 025.00 8 025.00
BJ TOTAL (I) 1 591 796.00 93 741.00 1 498 055.00 1 591 796.00
BZ Other receivables 178 373.00 178 373.00 178 373.00
CF Cash and cash equivalents 74 583.00 74 583.00 74 583.00
CH Prepaid expenses 306 117.00 306 117.00 306 117.00
CJ TOTAL (II) 559 072.00 559 072.00 559 072.00
CO Grand total (0 to V) 2 150 868.00 93 741.00 2 057 127.00 2 150 868.00
CX Development or Research and Development Expenses 1 379 830.00 18 917.00 1 360 912.00 1 379 830.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 31 950.00 26 750.00 31 950.00
DB Share, merger, contribution premiums, etc. 2 125 225.00 1 138 567.00 2 125 225.00
DH Retained earnings -654 472.00 -460 131.00 -654 472.00
DI RESULTS FOR THE YEAR (Profit or Loss) -241 920.00 -194 341.00 -241 920.00
DL TOTAL (I) 1 260 783.00 510 845.00 1 260 783.00
DN Conditional advances 471 787.00 496 443.00 471 787.00
DO TOTAL (II) 471 787.00 496 443.00 471 787.00
DU Loans and Debts from Credit Institutions (3) 959.00 959.00 959.00
DV Miscellaneous Loans and Financial Debts (4) 163 068.00 113 068.00 163 068.00
DX Trade payables and related accounts 139 455.00 252 466.00 139 455.00
DY Tax and social security liabilities 21 076.00 16 406.00 21 076.00
EC TOTAL (IV) 324 557.00 382 899.00 324 557.00
EE Grand total (I to V) 2 057 127.00 1 390 187.00 2 057 127.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FO Operating subsidies 45 791.00
FQ Other income 372 859.00
FR Total operating income (I) 418 650.00
FW Other purchases and external expenses 616 048.00
FX Taxes, duties, and similar payments 1 335.00
FY Salaries and Wages 102 310.00
FZ Social Security Contributions 20 357.00
GA Operating Expenses - Depreciation and Amortization 26 473.00
GE Other Expenses 51.00
GF Total Operating Expenses (II) 766 573.00
GG - OPERATING RESULT (I - II) -347 923.00
GP Total financial income (V) 537.00
GU Total financial expenses (VI) 6 135.00
GV - FINANCIAL INCOME (V - VI) -5 598.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -353 521.00
4 - Income statement (continued)Amount year NAmount year N-1
HD Total exceptional income (VII) 196.00 266.00 196.00
HI - EXCEPTIONAL RESULT (VII - VIII) 196.00 266.00 196.00
HK Income tax -111 405.00 -23 570.00 -111 405.00
HL TOTAL REVENUE (I + III + V + VII) 419 383.00 471 140.00 419 383.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 661 303.00 665 480.00 661 303.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -241 920.00 -194 341.00 -241 920.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 1 178 890.00 1 178 890.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 1 009 385.00 1 009 385.00
I3 DECREASES Total Financial Fixed Assets 8 025.00
I4 DECREASES Grand Total 1 591 796.00
IN DECREASES Start-up, development, or research expenses 1 379 830.00
IO DECREASES Total including other intangible assets 201 313.00
IY DECREASES Total Tangible Fixed Assets 2 629.00
KD ACQUISITIONS Total including other intangible assets 158 851.00 158 851.00
LN ACQUISITIONS Total Tangible Fixed Assets 2 629.00 2 629.00
LQ ACQUISITIONS Total Financial Fixed Assets 8 025.00 8 025.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 67 269.00 26 473.00 67 269.00
CY DEPRECIATION Start-up, development, or research expenses 18 917.00 18 917.00
PE DEPRECIATION Total including other intangible assets 46 409.00 26 086.00 46 409.00
QU DEPRECIATION Total Tangible Fixed Assets 1 942.00 386.00 1 942.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 110 000.00 66 000.00 110 000.00
8B Suppliers and Related Accounts 139 455.00 139 455.00 139 455.00
8K Other liabilities (including liabilities related to repo transactions) 53 068.00 53 068.00 53 068.00
UT Other financial assets 8 025.00 8 025.00
VH Loans with a maturity of more than one year at origin 959.00 959.00 959.00
VP Miscellaneous 178 372.00 178 372.00
VQ Other Taxes, Duties, and Similar Debts 21 076.00 21 076.00 21 076.00
VS Prepaid expenses 306 117.00 306 117.00
VT TOTAL – STATEMENT OF RECEIVABLES 492 515.00 484 490.00 8 025.00 492 515.00
VY TOTAL – STATEMENT OF LIABILITIES 324 557.00 214 557.00 66 000.00 324 557.00

all companies in France

Complete and comprehensive database.